Review the list of awards and select the Award Title link to see the required reporting data.
List of Awards for:
EMORY UNIVERSITY
1784 N DECATUR RD,S 530 NDBLDG
ATLANTA, GA 30322-1048
| DUNS Number |
Award Number | Award Title |
Agency | Fiscal Year | Issue Date | Funding Amount |
| 066469933 |
1C06RR030135-01 |
CONSTRUCTION OF A DUAL FUNCTION PRIMATE FACILITY: ABSL3 AND TRANSPLANT MEDICINE |
NIH |
2010 |
03-25-2010 |
$ 14,868,223 |
| 066469933 |
1F31AI084460-01 |
HIV-INDUCED 5-LIPOXYGENASE: ROLE IN HIV-RELATED PULMONARY ARTERIAL HYPERTENSION |
NIH |
2009 |
07-14-2009 |
$ 29,124 |
| 066469933 |
1F31DA026262-01 |
EFFECTS OF MGLUR2/3 ACTIVATION ON CUE-INDUCED COCAINE RELAPSE IN SQUIRREL MONKEYS |
NIH |
2009 |
05-05-2009 |
$ 29,118 |
| 066469933 |
1F32AI084409-01 |
HIV CTL ESCAPE MUTATION AND REVERSION IN LINKED PAIRS |
NIH |
2009 |
07-17-2009 |
$ 47,210 |
| 066469933 |
1P30GM092423-01 |
FACULTY POSTION IN COMPUTATIONAL PROTEIN DESIGN AND EVOLUTION |
NIH |
2009 |
09-30-2009 |
$ 360,000 |
| 066469933 |
1P30NS069250-01 |
SYSTEMS AND COMPUTATIONAL NEUROSCIENCE AT EMORY UNIVERSITY |
NIH |
2009 |
09-22-2009 |
$ 582,500 |
| 066469933 |
1P30NS069289-01 |
FACULTY RECRUITMENT IN NOVEL THERAPEUTIC STRATEGIES FOR NEURODEGENERATIVE DISEASE |
NIH |
2009 |
09-15-2009 |
$ 637,500 |
| 066469933 |
1R01AG028617-01A2 |
NOVEL PET LIGANDS FOR IN VIVO BINDING TO AMYLOID IN AD |
NIH |
2009 |
09-02-2009 |
$ 387,500 |
| 066469933 |
1R01AI084834-01 |
DEFINING NEUTRALIZATION BREADTH IN HIV+ HUMAN SERUM |
NIH |
2009 |
09-18-2009 |
$ 387,500 |
| 066469933 |
1R01DA023224-01A1 |
DESIGN OF NEW TREATMENT AGENTS FOR DRUG ABUSE |
NIH |
2009 |
07-14-2009 |
$ 393,200 |
| 066469933 |
1R01DA025045-01 |
NEUROBIOLOGICAL CIRCUITS OF GAIN AND LOSS DURING RISKY DECISION MAKING |
NIH |
2009 |
06-03-2009 |
$ 476,196 |
| 066469933 |
1R01DK081699-01A1 |
THE PATHOGENESIS OF SICKLE CELL NEPHROPATHY |
NIH |
2009 |
08-17-2009 |
$ 350,001 |
| 066469933 |
1R01HD061344-01A1 |
FMRP-MEDIATED TRANSLATION REGULATION IN NEURONAL DEVELOPMENT |
NIH |
2009 |
07-14-2009 |
$ 617,938 |
| 066469933 |
1R01HL083271-01A2 |
FUNCTIONAL COUPLING BETWEEN ITO AND ICA IN CARDIOMYOCYTES |
NIH |
2009 |
05-29-2009 |
$ 387,500 |
| 066469933 |
1R01HL092120-01A2 |
NOXR1, A REGULATOR OF NOX4-DEPENDENT CYTOSKELETAL REMODELING IN VASCULAR CELLS |
NIH |
2009 |
08-28-2009 |
$ 484,375 |
| 066469933 |
1R01HL096924-01 |
POLARITY OF REDOX CONTROL AND RISK OF INJURY IN THE ALVEOLAR EPITHELIUM |
NIH |
2009 |
08-31-2009 |
$ 397,025 |
| 066469933 |
1R01MH082813-01A1 |
MODELING OFFICER-LEVEL EFFECTS OF CRISIS INTERVENTION TEAM (CIT) TRAINING |
NIH |
2009 |
09-28-2009 |
$ 772,136 |
| 066469933 |
1R01MH089606-01 |
EPIGENETIC MARKS AS PERIPHERAL BIOMARKERS OF AUTISM |
NIH |
2009 |
09-21-2009 |
$ 2,198,844 |
| 066469933 |
1R03CA136059-01A2 |
DIETARY INORGANIC PHOSPHATE AS A TARGET FOR NUTRITIONAL INTERVENTION IN CANCER |
NIH |
2009 |
07-16-2009 |
$ 77,500 |
| 066469933 |
1R03HD058777-01A1 |
IMPACT OF VIDEO VIEWING ON INFANT LEARNING: USING BABY SIGNS AS AN EXPERIMENTAL A |
NIH |
2009 |
05-05-2009 |
$ 77,500 |
| 066469933 |
1R03HD059993-01A1 |
GENERAL MAGNITUDE REPRESENTATION IN INFANCY: TESTING THE ASSOCIATIONS AMONG SPACE |
NIH |
2009 |
08-31-2009 |
$ 77,432 |
| 066469933 |
1R03HL097012-01 |
VITAMIN D STATUS IN PULMONARY FIBROSIS |
NIH |
2009 |
05-06-2009 |
$ 77,500 |
| 066469933 |
1R03NS066378-01 |
PATIENTS' EXPERIENCES OF EMERGENCY RESEARCH (PEER)- VIEWS OF PATIENTS INCLUDED IN |
NIH |
2009 |
06-05-2009 |
$ 88,525 |
| 066469933 |
1R21AG032104-01A1 |
MAGNETIC RESONANCE SPECTROSCOPY BASED METABOLOMICS FOR ALZHEIMER'S DISEASE |
NIH |
2009 |
05-14-2009 |
$ 132,328 |
| 066469933 |
1R21AI083554-01 |
THE ROLE OF JAM-A IN REGULATING INTESTINAL ANTIGEN PRESENTING CELL FUNCTION AND I |
NIH |
2009 |
08-28-2009 |
$ 193,750 |
| 066469933 |
1R21DA027080-01 |
IDENTIFICATION OF LOCALIZED MIRNAS FOR NEURONAL DEVELOPMENT AND PLASTICITY |
NIH |
2009 |
05-18-2009 |
$ 232,500 |
| 066469933 |
1R21HL091385-01 |
ROLE OF SYK AND RAC2 IN REGULATION OF HIF1ALPHA AND NEOVASCULARIZATION. |
NIH |
2009 |
05-13-2009 |
$ 49,338 |
| 066469933 |
1R21MH083138-01A1 |
SCHIZOPHRENIA BIOMARKERS DISCERNED BY CELLULAR NETWORKS IN DIGEORGE SYNDROME |
NIH |
2009 |
04-27-2009 |
$ 232,500 |
| 066469933 |
1R21MH085210-01A1 |
DEVELOPMENT OF A NOVEL NF-KB ANTAGONIST TO BLOCK CYTOKINE-INDUCED BEHAVIORAL CHAN |
NIH |
2009 |
08-13-2009 |
$ 192,789 |
| 066469933 |
1R21NR011204-01 |
IMPROVING SELF MANAGEMENT AND OUTCOMES IN HEART FAILURE PATIENTS WITH DIABETES |
NIH |
2009 |
08-28-2009 |
$ 193,750 |
| 066469933 |
1R21NS066155-01 |
TOWARDS THE DEVELOPMENT OF A NOVEL TREATMENT FOR EPILEPSY |
NIH |
2009 |
07-17-2009 |
$ 232,500 |
| 066469933 |
1R21RR025822-01 |
ANALYSIS OF UBIQUITINATED PROTEOME |
NIH |
2009 |
09-24-2009 |
$ 271,250 |
| 066469933 |
1R24TW008825-01 |
EMORY-ETHIOPIA GLOBAL INTERDISCIPLINARY PARTNERSHIP |
NIH |
2010 |
09-27-2010 |
$ 270,000 |
| 066469933 |
1R34MH086331-01A1 |
ADAPTATION OF COUPLES VOLUNTARY COUNSELING AND TESTING (CVCT) FOR US MSM |
NIH |
2009 |
08-07-2009 |
$ 357,170 |
| 066469933 |
1R56DK084987-01 |
INTESTINAL PEPT1 IN HEALTH AND DISEASE |
NIH |
2010 |
07-19-2010 |
$ 124,269 |
| 066469933 |
1R56DK089763-01 |
FORMYL PEPTIDE RECEPTORS AS MEDIATORS OF INTESTINAL MUCOSAL HOMEOSTASIS |
NIH |
2010 |
07-12-2010 |
$ 741,299 |
| 066469933 |
1RC1AI081273-01 |
BLOCKADE OF THE SDF-1/CXCR4 AXIS AS A NOVEL STRATEGY FOR MITIGATING RADIATION-IND |
NIH |
2010 |
06-14-2010 |
$ 850,335 |
| 066469933 |
1RC1DK086939-01 |
KIDNEY INJURY AND DYSFUNCTION SUPPORT (KIDS) |
NIH |
2009 |
09-21-2009 |
$ 500,000 |
| 066469933 |
1RC1ES018299-01 |
VALIDATION & PILOT TESTING OF METHODS FOR ASSESSING INFANTS' DIETARY PESTICIDE EX |
NIH |
2009 |
09-21-2009 |
$ 259,069 |
| 066469933 |
1RC1GM090950-01 |
CHARACTERIZATION OF THE TRANSCRIPTOME IN AN EMERGING MODEL FOR SOCIAL BEHAVIOR |
NIH |
2009 |
09-25-2009 |
$ 426,250 |
| 066469933 |
1RC1GM091388-01 |
NUCLEAR ORGANIZATION IN STEM AND DIFFERENTIATED CELLS |
NIH |
2009 |
09-24-2009 |
$ 387,500 |
| 066469933 |
1RC1GM092035-01 |
GENERATION OF INDUCED PLURIPOTENT STEM CELLS WITH NOVEL SMALL MOLECULE REGULATOR |
NIH |
2010 |
03-23-2010 |
$ 1,000,000 |
| 066469933 |
1RC1HL100915-01 |
ECONOMIC CONSEQUENCES OF ADVANCED TESTING FOR SUBCLINICAL CARDIOVASCULAR DISEASE |
NIH |
2009 |
09-18-2009 |
$ 498,026 |
| 066469933 |
1RC1HL100951-01 |
HYBRID REVASCULARIZATION VS PERCUTANEOUS CORONARY INTERVENTION: A PLANNING GRANT |
NIH |
2009 |
09-15-2009 |
$ 500,000 |
| 066469933 |
1RC1MD004370-01 |
IMPROVING RACIAL/ETHNIC MINORITY PARTICIPATION IN ONLINE HIV PREVENTION RESEARCH |
NIH |
2009 |
09-22-2009 |
$ 499,526 |
| 066469933 |
1RC1MD004563-01 |
PREVENTING DEPRESSION IN PEOPLE WITH EPILEPSY: AN EXTENSION OF PROJECT UPLIFT |
NIH |
2009 |
09-18-2009 |
$ 491,782 |
| 066469933 |
1RC1MH088467-01 |
PREFRONTAL CORTEX BDNF AND AMYGDALA-DEPENDENT EMOTIONAL LEARNINGCHALLENGE AREA: |
NIH |
2009 |
09-23-2009 |
$ 394,308 |
| 066469933 |
1RC1MH088609-01 |
EPIGENETIC BIOMARKERS OF EARLY PSYCHOTROPIC MEDICATION EXPOSURE |
NIH |
2009 |
09-23-2009 |
$ 494,115 |
| 066469933 |
1RC1MH088985-01 |
SAFETY SIGNAL LEARNING IN RHESUS MONKEYS FOLLOWING EARLY LIFE STRESSCHALLENGE AR |
NIH |
2009 |
09-21-2009 |
$ 392,964 |
| 066469933 |
1RC1NS069234-01 |
NEW FRONTIERS IN OPMD: STEM CELL THEORY OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY |
NIH |
2009 |
09-23-2009 |
$ 500,000 |
| 066469933 |
1RC1NS069541-01 |
COMPREHENSIVE MUTATION DETECTION FOR NEUROMUSCULAR DISORDERS: BRINGING NEW TECHNO |
NIH |
2009 |
09-24-2009 |
$ 500,000 |
| 066469933 |
1RC2CA148265-01 |
NANOTECHNOLOGY FOR MULTIPLEXED AND INTRAOPERATIVE CANCER DETECTION |
NIH |
2009 |
09-30-2009 |
$ 980,999 |
| 066469933 |
1RC2CA149086-01 |
PD-1 BLOCKADE COMBINED WITH VACCINATION AS A THERAPY FOR SIV/AIDS |
NIH |
2009 |
09-28-2009 |
$ 499,984 |
| 066469933 |
1RC2HD064525-01 |
CNV ATLAS OF HUMAN DEVELOPMENT |
NIH |
2009 |
09-30-2009 |
$ 1,727,519 |
| 066469933 |
1RC2HG005542-01 |
DYNAMICALLY SCALABLE ACCESSIBLE ANALYSIS FOR NEXT GENERATION SEQUENCE DATA |
NIH |
2009 |
09-22-2009 |
$ 780,798 |
| 066469933 |
1RC2HL101515-01 |
PHASE II STUDY: MOBILIZATION OF PROGENITOR CELLS IN PERIPHERAL ARTERIAL DISEASE |
NIH |
2009 |
09-24-2009 |
$ 1,180,494 |
| 066469933 |
1RC4AG039071-01 |
UPTAKE OF COMPARATIVE EFFECTIVENESS RESEARCH: IMPLICATIONS FOR DISCHARGE DECISION |
NIH |
2010 |
09-21-2010 |
$ 1,171,865 |
| 066469933 |
1RC4NR012527-01 |
ACCESSIBLE HANDLING OF MISCLASSIFIED OR MISSING BINARY VARIABLES IN CER STUDIES |
NIH |
2010 |
09-24-2010 |
$ 441,691 |
| 066469933 |
1S07TW008847-01 |
PHFI-EMORY PARTNERSHIP FOR SEAMLESS, THOROUGH AND EFFICIENT HUMAN SUBJECTS RESEAR |
NIH |
2010 |
09-25-2010 |
$ 54,170 |
| 066469933 |
1S10RR025679-01 |
FEI TRANSMISSION ELECTRON MICROSCOPE WITH TOMOGRAPHY CAPABILITY |
NIH |
2009 |
04-27-2009 |
$ 500,000 |
| 066469933 |
1S10RR027151-01 |
TYPHOON TRIO PHOSPHOR IMAGING SYSTEM |
NIH |
2010 |
02-18-2010 |
$ 139,709 |
| 066469933 |
1U19AI090023-01 |
SYSTEMS BIOLOGICAL ANALYSIS OF INNATE AND ADAPTIVE RESPONSES TO VACCINATION |
NIH |
2010 |
07-12-2010 |
$ 3,213,142 |
| 066469933 |
2P01AI044644-10 |
INTERACTIONS OF PROTECTIVE IMMUNITY AND TRANSPLANTATION TOLERANCE |
NIH |
2009 |
07-17-2009 |
$ 1,101,384 |
| 066469933 |
2R01AI020723-24A2 |
GENETIC ANALYSIS OF S. PYOGENES VIRULENCE FACTORS |
NIH |
2009 |
05-19-2009 |
$ 482,503 |
| 066469933 |
2R01AI058057-06A1 |
FUNCTION OF THE GAMMA HV68 M2 ANTIGEN |
NIH |
2009 |
07-17-2009 |
$ 389,276 |
| 066469933 |
2R01AR050501-06 |
CADHERIN REGULATION IN DERMAL ENDOTHELIAL CELLS |
NIH |
2009 |
09-16-2009 |
$ 386,114 |
| 066469933 |
2R01CA090860-05A2 |
REPAIR OF CLUSTERED DNA DAMAGES |
NIH |
2009 |
06-03-2009 |
$ 238,877 |
| 066469933 |
2R01HL040921-18A1 |
STRUCTURE AND FUNCTION OF THE FACTOR VIII - VON WILLEBRAND FACTOR COMPLEX |
NIH |
2009 |
05-29-2009 |
$ 386,772 |
| 066469933 |
2R01HL068630-06A2 |
MECHANISMS LINKING DEPRESSION TO CARDIOVASCULAR RISK |
NIH |
2009 |
08-12-2009 |
$ 780,847 |
| 066469933 |
2R01HL082609-05 |
THE IMMUNE RESPONSE TO FACTOR VIII |
NIH |
2009 |
09-07-2009 |
$ 483,647 |
| 066469933 |
3D43TW001042-11S1 |
EMORY AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM |
NIH |
2009 |
09-02-2009 |
$ 21,596 |
| 066469933 |
3D43TW007124-06S1 |
EMORY-GEORGIA TB RESEARCH TRAINING PROGRAM |
NIH |
2009 |
09-01-2009 |
$ 172,186 |
| 066469933 |
3D43TW007262-05S1 |
INTERNATIONAL TRAINING IN INJURY CONTROL RESEARCH |
NIH |
2009 |
09-01-2009 |
$ 76,771 |
| 066469933 |
3K01CA114313-04S1 |
ULTRASONIC TISSUE-TYPING-GUIDED PROSTATE BRACHYTHERAPY |
NIH |
2009 |
09-14-2009 |
$ 100,392 |
| 066469933 |
3K01CA118174-05S1 |
HER-2/IGF-IR CROSS-TALK AND HERCEPTIN RESISTANCE |
NIH |
2009 |
09-15-2009 |
$ 109,620 |
| 066469933 |
3K01DK076742-03S1 |
PROLIFERATIVE RESPONSES TO ENTERIC BACTERIAL PATHOGENS IN INTESTINAL TISSUES |
NIH |
2009 |
08-12-2009 |
$ 54,000 |
| 066469933 |
3K01DK078513-02S1 |
MECHANISMS OF TENOFOVIR RENAL TUBULAR TOXICITY |
NIH |
2010 |
01-01-2010 |
$ 54,000 |
| 066469933 |
3K01DK082733-02S1 |
CYCLIC AMP SIGNALING AFFECTS URINE CONCENTRATION THROUGH UT-A1 |
NIH |
2010 |
12-17-2009 |
$ 54,000 |
| 066469933 |
3K08CA128925-03S1 |
OPTIMIZING PRO-APOPTOTIC THERAPEUTICS WITH KINASE INHIBITION IN NEUROBLASTOMA |
NIH |
2009 |
09-29-2009 |
$ 108,000 |
| 066469933 |
3K08DK068226-06S1 |
SODIUM CHLORIDE COTRANSPORTER REGULATION BY WNK KINASE |
NIH |
2010 |
01-08-2010 |
$ 54,000 |
| 066469933 |
3K08DK070668-06S1 |
REGULATION OF THE SODIUM CHLORIDE COTRANSPORTER |
NIH |
2011 |
01-28-2011 |
$ 53,320 |
| 066469933 |
3K08NS046322-05S1 |
AXON GUIDANCE MOLECULES IN NIGROSTRIATAL REGENERATION |
NIH |
2009 |
07-20-2009 |
$ 7,560 |
| 066469933 |
3K12GM000680-10S1 |
INSTITUTIONAL RESEARCH AND ACADEMIC CAREER DEVELOPMENT |
NIH |
2009 |
08-21-2009 |
$ 301,075 |
| 066469933 |
3K22CA127136-03S1 |
TUMOR ENDOTHELIUM MARKER 8 MEDIATED ADHESION IN TUMOR ASSOCIATED VASCULATURE |
NIH |
2009 |
09-29-2009 |
$ 50,000 |
| 066469933 |
3P01DK061521-05S1 |
CELLULAR SIGNALING AND KIDNEY FUNCTION |
NIH |
2009 |
07-13-2009 |
$ 29,797 |
| 066469933 |
3P01ES016731-03S1 |
EMORY PARKINSON'S DISEASE COLLABORATIVE ENVIRONMENTAL RESEARCH CENTER |
NIH |
2010 |
07-01-2010 |
$ 77,449 |
| 066469933 |
3P01ES016731-03S2 |
EMORY PARKINSON'S DISEASE COLLABORATIVE ENVIRONMENTAL RESEARCH CENTER |
NIH |
2010 |
07-02-2010 |
$ 116,250 |
| 066469933 |
3P01HD032571-14S1 |
SPINAL CIRCUITS AND THE MUSCULOSKELETAL SYSTEM |
NIH |
2010 |
08-25-2010 |
$ 169,225 |
| 066469933 |
3P01NR011587-01S1 |
CAREGIVER STRESS: INTERVENTIONS TO PROMOTE HEALTH AND WELLBEING |
NIH |
2010 |
05-13-2010 |
$ 11,673 |
| 066469933 |
3P30CA138292-01S2 |
WINSHIP CANCER INSTITUTE CANCER CENTER SUPPORT GRANT |
NIH |
2009 |
09-30-2009 |
$ 50,000 |
| 066469933 |
3P51RR000165-49S1 |
SUPPORT OF YERKES NATIONAL PRIMATE RESEARCH CENTER |
NIH |
2009 |
06-05-2009 |
$ 192,292 |
| 066469933 |
3P51RR000165-49S2 |
SUPPORT OF YERKES NATIONAL PRIMATE RESEARCH CENTER |
NIH |
2009 |
09-18-2009 |
$ 494,676 |
| 066469933 |
3P51RR000165-49S3 |
SUPPORT OF YERKES NATIONAL PRIMATE RESEARCH CENTER |
NIH |
2009 |
09-28-2009 |
$ 844,480 |
| 066469933 |
3R01AG028278-03S1 |
OVARIECTOMY INDUCED T CELL INFLAMMATORY CYTOKINES/BONE LOSS IN YOUNG & OLD MICE |
NIH |
2009 |
06-18-2009 |
$ 18,600 |
| 066469933 |
3R01AI034000-15S1 |
MHC CLASS II TRANSACTIVATOR FUNCTION AND REGULATION |
NIH |
2009 |
09-14-2009 |
$ 195,000 |
| 066469933 |
3R01AI064060-06A1S1 |
CTL AND HIV POLYMORPHISMS IN HETEROSEXUAL TRANSMISSION |
NIH |
2010 |
05-17-2010 |
$ 250,582 |
| 066469933 |
3R01AI068003-04S1 |
NOVEL VLP VACCINES FOR PANDEMIC INFLUENZA VIRUS |
NIH |
2009 |
09-07-2009 |
$ 162,855 |
| 066469933 |
3R01AI073707-02S1 |
DETERMINANTS OF T CELL FATE IN TRANSPLANTATION |
NIH |
2009 |
09-15-2009 |
$ 178,250 |
| 066469933 |
3R01AI078773-02S1 |
INNATE IMMUNITY AND SIV INFECTION |
NIH |
2010 |
05-10-2010 |
$ 155,000 |
| 066469933 |
3R01AR051466-05S1 |
USING C. ELEGANS TO STUDY TITIN AND OBSCURIN (UNC-89) |
NIH |
2009 |
06-08-2009 |
$ 10,075 |
| 066469933 |
3R01AT004698-01A1S1 |
MECHANISMS OF MEDITATION |
NIH |
2009 |
09-16-2009 |
$ 551,083 |
| 066469933 |
3R01CA057327-17S1 |
CELLULAR TARGETS OF POLYOMAVIRUS TUMOR ANTIGENS |
NIH |
2009 |
08-28-2009 |
$ 64,001 |
| 066469933 |
3R01CA084138-08S1 |
MOX 1: A NOVEL MITOGENIC OXIDASE |
NIH |
2009 |
09-22-2009 |
$ 643,253 |
| 066469933 |
3R01DC006483-04S2 |
ROLE OF CONNEXINS IN COCHLEAR FUNCTIONS |
NIH |
2009 |
07-17-2009 |
$ 43,358 |
| 066469933 |
3R01DC008343-03S1 |
FUNCTIONAL APPROACH TO COMMUNICATION SOUND PROCESSING IN MOUSE AUDITORY CORTEX |
NIH |
2009 |
07-15-2009 |
$ 135,625 |
| 066469933 |
3R01DC008648-02S1 |
PHYSIOLOGICAL ANALYSIS OF RETRONASAL OLFACTION |
NIH |
2009 |
05-29-2009 |
$ 7,688 |
| 066469933 |
3R01DC008648-02S2 |
PHYSIOLOGICAL ANALYSIS OF RETRONASAL OLFACTION |
NIH |
2009 |
07-15-2009 |
$ 17,505 |
| 066469933 |
3R01DK041707-16S1 |
REGULATION OF RAT RENAL INNER MEDULLARY FUNCTION |
NIH |
2009 |
08-14-2009 |
$ 100,000 |
| 066469933 |
3R01DK050740-11S1 |
MUSCLE-SPECIFIC NUTRITIONAL ADAPTATIONS TO CATABOLIC STATES |
NIH |
2010 |
12-07-2009 |
$ 100,000 |
| 066469933 |
3R01DK052230-13S2 |
REGULATION OF INTESTINAL EPITHELIAL CELL PROLIFERATION |
NIH |
2009 |
08-13-2009 |
$ 79,332 |
| 066469933 |
3R01DK052935-11S1 |
REGULATION OF PENDRIN BY ANGIOTENSIN II |
NIH |
2010 |
12-08-2009 |
$ 103,100 |
| 066469933 |
3R01DK059904-08S2 |
BASES OF PATHOPHYSIOLOGY IN GALACTOSEMIA |
NIH |
2010 |
01-30-2010 |
$ 154,463 |
| 066469933 |
3R01DK061379-08S1 |
STRUCTURE FUNCTION STUDIES IN INTESTINAL EPITHELIAL JAM |
NIH |
2009 |
08-12-2009 |
$ 37,975 |
| 066469933 |
3R01DK061417-07S1 |
FLAGELLIN-INDUCED GUT EPITHELIAL CHEMOKINE SECRETION |
NIH |
2009 |
09-29-2009 |
$ 524,750 |
| 066469933 |
3R01DK061417-07S2 |
FLAGELLIN-INDUCED GUT EPITHELIAL CHEMOKINE SECRETION |
NIH |
2010 |
01-19-2010 |
$ 101,600 |
| 066469933 |
3R01DK061418-06A1S1 |
REGULATION OF NA ABSORPTION BY NHE3 IN THE INTESTINE |
NIH |
2009 |
08-31-2009 |
$ 81,355 |
| 066469933 |
3R01DK062081-05S1 |
REGULATION OF UREA TRANSPORT IN DIABETIC RAT KIDNEY |
NIH |
2009 |
07-13-2009 |
$ 15,500 |
| 066469933 |
3R01DK062092-07S1 |
MULTIPLE MOLECULAR MECHANISMS FOR ADIPONECTIN THERAPY IN HEPATIC FIBROGENESIS |
NIH |
2009 |
09-01-2009 |
$ 99,820 |
| 066469933 |
3R01DK064711-05S1 |
NEUTROPHIL-EPITHELIAL INTERACTION MEDIATED BY ADENOSINE |
NIH |
2009 |
09-16-2009 |
$ 99,906 |
| 066469933 |
3R01DK069681-04S1 |
PYROPHOSPHATE IN VASCULAR CALCIFICATION OF RENAL FAILURE |
NIH |
2009 |
09-07-2009 |
$ 68,541 |
| 066469933 |
3R01DK071597-03S1 |
LPA RECEPTOR SIGNALING IN COLONIC EPITHELIA |
NIH |
2009 |
09-16-2009 |
$ 99,002 |
| 066469933 |
3R01DK072564-15S1 |
NEUTROPHIL INTERACTIONS WITH INTESTINAL EPITHELIAL CELLS |
NIH |
2009 |
09-24-2009 |
$ 310,000 |
| 066469933 |
3R01DK074731-02S1 |
A C.ELEGANS MODEL FOR EPEC AND EHEC PATHOGENESIS |
NIH |
2009 |
09-29-2009 |
$ 99,984 |
| 066469933 |
3R01DK076825-02S1 |
ROLE AND REGULATION OF METALLOPROTEINASE-9 IN THE INTESTINE |
NIH |
2010 |
02-23-2010 |
$ 50,440 |
| 066469933 |
3R01DK079713-03S1 |
PROJECT ACTS II: INCREASING DONOR REGISTRATION AMONG AFRICAN AMERICANS |
NIH |
2009 |
09-21-2009 |
$ 65,947 |
| 066469933 |
3R01DK081699-01A1S1 |
THE PATHOGENESIS OF SICKLE CELL NEPHROPATHY |
NIH |
2010 |
01-01-2010 |
$ 77,500 |
| 066469933 |
3R01GM029433-26S1 |
COVALENT FLAVIN COENZYMES IN FLAVOENZYME CATALYSIS |
NIH |
2009 |
09-30-2009 |
$ 89,745 |
| 066469933 |
3R01GM030308-28S1 |
UBIQUITIN-DEPENDENT PROTEOLYSIS: SPECIFICITY & MECHANISM |
NIH |
2009 |
09-30-2009 |
$ 226,774 |
| 066469933 |
3R01GM046331-17S1 |
RNA POLYMERASE II ELONGATION COMPLEX: STRUCTURE AND FUNCTION |
NIH |
2009 |
09-08-2009 |
$ 82,339 |
| 066469933 |
3R01GM049245-17A1S1 |
DNA METHYLATION: STRUCTURES, FUNCTIONS, AND REGULATION |
NIH |
2010 |
09-30-2010 |
$ 97,439 |
| 066469933 |
3R01GM066202-08S1 |
GUT EPITHELIAL APOPOTOSIS IN SHOCK AND SEPSIS |
NIH |
2010 |
09-01-2010 |
$ 102,325 |
| 066469933 |
3R01GM068559-05S1 |
COSMC - A NOVEL MOLECULAR CHAPERONE REGULATING O-GLYCANS |
NIH |
2009 |
09-30-2009 |
$ 73,486 |
| 066469933 |
3R01GM068680-06S1 |
HISTONE LYSINE METHYLATION: STRUCTURES AND FUNCTIONS |
NIH |
2010 |
08-30-2010 |
$ 98,678 |
| 066469933 |
3R01GM078502-03S1 |
STRUCTURE/FUNCTION ANALYSIS OF THE NA/BICARBONATE COTRANSPORTERS |
NIH |
2009 |
09-30-2009 |
$ 247,488 |
| 066469933 |
3R01GM080754-01A2S1 |
CELLULAR RESPONSES TO RADIATION AND OTHER TYPES OF DAMAGE |
NIH |
2009 |
09-08-2009 |
$ 61,738 |
| 066469933 |
3R01GM080771-03S1 |
A NEW ROLE OF MEPE/OF45 AS A CO-FACTOR OF CHK1 FOR DNA DAMAGE RESPONSE |
NIH |
2009 |
09-08-2009 |
$ 310,020 |
| 066469933 |
3R01GM082828-02S1 |
THE PINK1 MITOCHONDRIAL SIGNALING PATHWAY |
NIH |
2009 |
08-31-2009 |
$ 273,352 |
| 066469933 |
3R01GM084363-02S1 |
DIRECTED GROWTH CONE MIGRATION BY CALCIUM SIGNALS |
NIH |
2009 |
09-30-2009 |
$ 60,000 |
| 066469933 |
3R01GM085448-02S1 |
SHOTGUN GLYCOMICS: LINKING GLYCAN STRUCTURE AND FUNCTION |
NIH |
2009 |
09-30-2009 |
$ 635,483 |
| 066469933 |
3R01GM085448-02S2 |
SHOTGUN GLYCOMICS: LINKING GLYCAN STRUCTURE AND FUNCTION |
NIH |
2009 |
08-11-2009 |
$ 410,820 |
| 066469933 |
3R01HD055379-03S1 |
RETINOID EFFECTS ON INFLAMMATION AND CELL GROWTH ASSOCIATED WITH ENDOMETRIOSIS |
NIH |
2010 |
07-29-2010 |
$ 155,873 |
| 066469933 |
3R01HD055835-03S1 |
SPINAL MUSCULAR ATROPHY: SMNS ROLE IN MRNA LOCALIZATION AND LOCAL TRANSLATION |
NIH |
2009 |
09-29-2009 |
$ 245,138 |
| 066469933 |
3R01HL058863-11S1 |
VASCULAR OXIDASES IN MIGRATION |
NIH |
2009 |
05-29-2009 |
$ 7,556 |
| 066469933 |
3R01HL070531-06A1S1 |
BIOLOGY, BIOMECHANICS AND ATHEROSCLEROSIS |
NIH |
2009 |
06-03-2009 |
$ 18,600 |
| 066469933 |
3R01HL088488-02S2 |
EXCITATION-CONTRACTION COUPLING IN HUMAN VENTRICLE DEVELOPMENT |
NIH |
2009 |
07-15-2009 |
$ 264,184 |
| 066469933 |
3R01HL090851-02S1 |
NOX4 AND CARDIAC FIBROSIS |
NIH |
2009 |
07-10-2009 |
$ 273,118 |
| 066469933 |
3R01HL093196-03S1 |
NITRATED FATTY ACIDS, NOVEL ANTI-INFLAMMATORY MEDIATOR IN ALLERGIC AIRWAY DISEASE |
NIH |
2010 |
08-30-2010 |
$ 106,821 |
| 066469933 |
3R01MH050268-14S1 |
AMYGDALA: SEX DIFFERENCES IN BEHAVIOR, COGNITION, AND NEUROENDOCRINE DEVELOPMENT |
NIH |
2010 |
09-27-2010 |
$ 277,495 |
| 066469933 |
3R01MH085617-05S1 |
IMAGING FMRP REGULATION AND FUNCTION |
NIH |
2009 |
06-02-2009 |
$ 31,000 |
| 066469933 |
3R01NR008800-04S1 |
A FAMILY PARTNERSHIP INTERVENTION FOR HEART FAILURE |
NIH |
2009 |
07-14-2009 |
$ 10,227 |
| 066469933 |
3R01NR011888-01S1 |
COST EFFECTIVENESS AND QUALITY OF LIFE IN HEART FAILURE PATIENTS WITH DIABETES |
NIH |
2010 |
05-13-2010 |
$ 11,673 |
| 066469933 |
3R01NS055015-03S1 |
CART REGULATION OF WAKEFULNESS |
NIH |
2009 |
09-25-2009 |
$ 297,600 |
| 066469933 |
3R01NS056380-03S1 |
THE ROLE OF MOUSE ARL13B IN CELL DIVERSIFICATION DURING SPINAL CORD DEVELOPMENT |
NIH |
2009 |
08-10-2009 |
$ 199,950 |
| 066469933 |
3R01NS057190-03S1 |
EXERCISE, NEUROTROPHINS, AND AXON REGENERATION IN THE PNS |
NIH |
2009 |
07-21-2009 |
$ 17,593 |
| 066469933 |
3R01NS058710-01A1S1 |
COMBINATION THERAPY IN HUMAN ES CELL TRANSPLANTATION AFTER NEONATAL STROKE |
NIH |
2009 |
09-25-2009 |
$ 183,749 |
| 066469933 |
3R03AI079765-02S1 |
A NOVEL APPROACH FOR DIAGNOSIS AND NEWBORN SCREENING FOR 22Q11 DELETION SYNDROME |
NIH |
2009 |
09-15-2009 |
$ 105,284 |
| 066469933 |
3R03HD054886-02S1 |
EYEBLINK CONDITIONING IN INFANTS AND ADULTS |
NIH |
2009 |
07-13-2009 |
$ 5,554 |
| 066469933 |
3R03HD057291-01S1 |
LINKING EPISODES IN MEMORY AND DEVELOPMENT |
NIH |
2009 |
07-13-2009 |
$ 5,554 |
| 066469933 |
3R21AT004509-01A2S1 |
MELATONIN AND NIGHTTIME BLOOD PRESSURE IN AFRICAN AMERICANS |
NIH |
2009 |
09-11-2009 |
$ 509,947 |
| 066469933 |
3R21DK080431-02S1 |
ISOLATION AND CHARACTERIZATION OF RAT KIDNEY ACTIVE UREA TRANSPORTER |
NIH |
2010 |
12-07-2009 |
$ 100,001 |
| 066469933 |
3R21HL087969-02S1 |
EXPLOITING NOVEL USES OF GENE-MODIFIED DRUG-RESISTANT HEMATOPOIETIC CELLS |
NIH |
2009 |
06-02-2009 |
$ 13,175 |
| 066469933 |
3R21HL089160-02S1 |
DETECTION OF LEFT VENTRICULAR DYSSYNCHRONY BY CROSS-CORRELATION ANALYSIS |
NIH |
2009 |
05-29-2009 |
$ 27,900 |
| 066469933 |
3R21HL091268-02S1 |
FC RECEPTOR TARGETED THERAPY FOR IMMUNE HEMOLYTIC ANEMIA |
NIH |
2009 |
05-29-2009 |
$ 17,980 |
| 066469933 |
3R21HL093665-01A1S1 |
SEX DIFFERENCES IN MYOCARDIAL ISCHEMIA TRIGGERED BY EMOTIONAL FACTORS AFTER MI |
NIH |
2009 |
07-15-2009 |
$ 291,952 |
| 066469933 |
3R24DK064399-07S1 |
EMORY EPITHELIAL PATHOBIOLOGY RESEARCH DEVELOPMENT CENTER |
NIH |
2009 |
07-17-2009 |
$ 99,901 |
| 066469933 |
3R24DK064399-07S2 |
EMORY EPITHELIAL PATHOBIOLOGY RESEARCH DEVELOPMENT CENTER |
NIH |
2010 |
01-18-2010 |
$ 49,945 |
| 066469933 |
3R24RR018827-05A1S1 |
ESTABLISHMENT OF A TRANSGENIC MONKEY MODEL OF HUNTINGTON'S DISEASE |
NIH |
2009 |
09-30-2009 |
$ 1,000,000 |
| 066469933 |
3R25RR024504-03S1 |
YNPRC NONHUMAN PRIMATE CLINICAL MEDICINE RESIDENCY PROGRAM |
NIH |
2009 |
08-20-2009 |
$ 169,829 |
| 066469933 |
3R25TW007733-03S1 |
FOSTERING GLOBAL HEALTH OPPORTUNITTIES AT EMORY AND ITS PARTNERS |
NIH |
2009 |
09-01-2009 |
$ 107,042 |
| 066469933 |
3R37AI021150-25S1 |
GONOCOCCI: GENETICS OF RESISTANCE TO PMN PROTEINS |
NIH |
2010 |
09-20-2010 |
$ 39,057 |
| 066469933 |
3R37AI039816-15S1 |
COMPARISON OF B CELL DIFFERENTIATION IN MICE AND HUMANS |
NIH |
2009 |
09-07-2009 |
$ 250,625 |
| 066469933 |
3R37AI051231-09S1 |
VIROLOGIC CORRELATES OF HETEROSEXUAL TRANSMISSION |
NIH |
2010 |
05-17-2010 |
$ 519,640 |
| 066469933 |
3R37DK037963-23S1 |
REGULATION OF SODIUM IN TIGHT EPITHELIA |
NIH |
2010 |
12-07-2009 |
$ 100,001 |
| 066469933 |
3R37GM051173-25S1 |
FUNCTIONAL SUBSTRUCTURE OF FLAGELLAR DYNEIN |
NIH |
2009 |
09-30-2009 |
$ 64,950 |
| 066469933 |
3R56AI076237-01A1S1 |
THE ROLE OF LEUKOCYTE SEQUESTRATION IN THE CONTROL OF VIRAL INFECTIONS |
NIH |
2009 |
05-28-2009 |
$ 433,692 |
| 066469933 |
3R56DK061941-06A2S1 |
HPEPT1 IN INTESTINAL INFLAMMATION |
NIH |
2009 |
09-18-2009 |
$ 54,403 |
| 066469933 |
3R56DK082678-01S1 |
IDENTIFICATION AND CHARACTERIZATION OF NOVEL EPIGENETIC MARKS OF NON-HISTONE PROT |
NIH |
2009 |
07-13-2009 |
$ 18,600 |
| 066469933 |
3R56DK082678-02S1 |
IDENTIFICATION AND CHARACTERIZATION OF NOVEL EPIGENETIC MARKS OF NON-HISTONE PROT |
NIH |
2010 |
02-01-2010 |
$ 20,000 |
| 066469933 |
3T32GM008490-17S1 |
PREDOCTORAL TRAINING PROGRAM IN GENETICS |
NIH |
2009 |
08-12-2009 |
$ 174,056 |
| 066469933 |
3T32GM008605-14S1 |
TRAINING IN SYSTEMS AND INTEGRATIVE BIOLOGY-NEUROSCIENCE |
NIH |
2009 |
08-12-2009 |
$ 261,084 |
| 066469933 |
3T32GM074909-05S1 |
BIOSTATISTICS IN GENETICS, IMMUNOLOGY AND NEUROIMAGING (BGIN) |
NIH |
2009 |
08-03-2009 |
$ 94,006 |
| 066469933 |
3U01AI069418-03S1 |
EMORY HIV/AIDS CLINICAL TRIALS UNIT |
NIH |
2009 |
08-28-2009 |
$ 4,827,520 |
| 066469933 |
3U01AI069418-04S1 |
EMORY HIV/AIDS CLINICAL TRIALS UNIT |
NIH |
2010 |
05-24-2010 |
$ 499,534 |
| 066469933 |
3U01AI077821-02S1 |
DEVELOPMENT OF TRANSPLANT STRATEGIES UNIQUELY RESPONSIVE TO THE NEEDS OF CHILDREN |
NIH |
2009 |
07-30-2009 |
$ 1,649,526 |
| 066469933 |
3U01AI077821-03S1 |
DEVELOPMENT OF TRANSPLANT STRATEGIES UNIQUELY RESPONSIVE TO THE NEEDS OF CHILDREN |
NIH |
2010 |
09-13-2010 |
$ 78,517 |
| 066469933 |
3U01DK062408-08S1 |
LIMITED COMPETITION: CLINICAL CENTERS FOR THE HALT-POLYCYSTIC KIDNEY DISEASE TRIA |
NIH |
2009 |
09-17-2009 |
$ 110,085 |
| 066469933 |
3U01DK069322-05S2 |
EFFICACY AND MECHANISMS OF GLN DIPEPTIDE IN THE SICU |
NIH |
2009 |
09-09-2009 |
$ 150,000 |
| 066469933 |
3U01MH066807-05S2 |
A MULTILEVEL HIV-PREVENTION STRATEGY FOR HIGH-RISK YOUTH |
NIH |
2009 |
09-29-2009 |
$ 223,748 |
| 066469933 |
3U19AI051731-08S1 |
TRANSPLANT TOLERANCE IN NON-HUMAN PRIMATES |
NIH |
2009 |
09-07-2009 |
$ 232,500 |
| 066469933 |
3U19AI051731-09S1 |
TRANSPLANT TOLERANCE IN NON-HUMAN PRIMATES |
NIH |
2010 |
07-26-2010 |
$ 499,863 |
| 066469933 |
3U19AI057266-06S1 |
VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGED |
NIH |
2009 |
08-28-2009 |
$ 1,280,745 |
| 066469933 |
3U19AI057266-06S2 |
VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGED |
NIH |
2009 |
09-15-2009 |
$ 2,462,810 |
| 066469933 |
3U24RR018109-07S1 |
SPF BREEDING COLONIES AT THE YERKES NPRC |
NIH |
2009 |
08-28-2009 |
$ 486,623 |
| 066469933 |
3U54CA119338-05S1 |
EMORY-GA TECH NANOTECHNOLOGY CENTER FOR PERSONALIZED AN* |
NIH |
2009 |
09-23-2009 |
$ 300,000 |
| 066469933 |
3UL1RR025008-03S1 |
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (UL1) |
NIH |
2009 |
09-02-2009 |
$ 599,998 |
| 066469933 |
3UL1RR025008-03S2 |
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (UL1) |
NIH |
2009 |
09-03-2009 |
$ 998,826 |
| 066469933 |
5F31AI084460-02 |
HIV-INDUCED 5-LIPOXYGENASE: ROLE IN HIV-RELATED PULMONARY ARTERIAL HYPERTENSION |
NIH |
2010 |
06-03-2010 |
$ 29,328 |
| 066469933 |
5F31DA026262-02 |
EFFECTS OF MGLUR2/3 ACTIVATION ON CUE-INDUCED COCAINE RELAPSE IN SQUIRREL MONKEYS |
NIH |
2010 |
06-15-2010 |
$ 30,060 |
| 066469933 |
5F32AI084409-02 |
HIV CTL ESCAPE MUTATION AND REVERSION IN LINKED PAIRS |
NIH |
2010 |
08-24-2010 |
$ 50,474 |
| 066469933 |
5P01AI044644-11 |
INTERACTIONS OF PROTECTIVE IMMUNITY AND TRANSPLANTATION TOLERANCE |
NIH |
2010 |
06-23-2010 |
$ 1,101,384 |
| 066469933 |
5P30GM092423-02 |
FACULTY POSTION IN COMPUTATIONAL PROTEIN DESIGN AND EVOLUTION |
NIH |
2010 |
09-03-2010 |
$ 358,328 |
| 066469933 |
5P30NS069250-02 |
SYSTEMS AND COMPUTATIONAL NEUROSCIENCE AT EMORY UNIVERSITY |
NIH |
2010 |
08-19-2010 |
$ 610,000 |
| 066469933 |
5P30NS069289-02 |
FACULTY RECRUITMENT IN NOVEL THERAPEUTIC STRATEGIES FOR NEURODEGENERATIVE DISEASE |
NIH |
2010 |
08-23-2010 |
$ 747,500 |
| 066469933 |
5R01AG028617-02 |
NOVEL PET LIGANDS FOR IN VIVO BINDING TO AMYLOID IN AD |
NIH |
2010 |
07-26-2010 |
$ 388,551 |
| 066469933 |
5R01AI020723-25 |
GENETIC ANALYSIS OF S. PYOGENES VIRULENCE FACTORS |
NIH |
2010 |
04-12-2010 |
$ 482,503 |
| 066469933 |
5R01AI058057-07 |
FUNCTION OF THE GAMMA HV68 M2 ANTIGEN |
NIH |
2010 |
06-17-2010 |
$ 420,644 |
| 066469933 |
5R01AI084834-02 |
DEFINING NEUTRALIZATION BREADTH IN HIV+ HUMAN SERUM |
NIH |
2010 |
08-12-2010 |
$ 387,500 |
| 066469933 |
5R01AR050501-07 |
CADHERIN REGULATION IN DERMAL ENDOTHELIAL CELLS |
NIH |
2010 |
08-05-2010 |
$ 385,438 |
| 066469933 |
5R01CA090860-06 |
REPAIR OF CLUSTERED DNA DAMAGES |
NIH |
2010 |
07-26-2010 |
$ 238,877 |
| 066469933 |
5R01DA023224-02 |
DESIGN OF NEW TREATMENT AGENTS FOR DRUG ABUSE |
NIH |
2010 |
07-12-2010 |
$ 379,450 |
| 066469933 |
5R01DA025045-02 |
NEUROBIOLOGICAL CIRCUITS OF GAIN AND LOSS DURING RISKY DECISION MAKING |
NIH |
2010 |
05-26-2010 |
$ 470,983 |
| 066469933 |
5R01DK081699-02 |
THE PATHOGENESIS OF SICKLE CELL NEPHROPATHY |
NIH |
2010 |
09-23-2010 |
$ 350,001 |
| 066469933 |
5R01HD061344-02 |
FMRP-MEDIATED TRANSLATION REGULATION IN NEURONAL DEVELOPMENT |
NIH |
2010 |
08-04-2010 |
$ 628,226 |
| 066469933 |
5R01HL040921-19 |
STRUCTURE AND FUNCTION OF THE FACTOR VIII - VON WILLEBRAND FACTOR COMPLEX |
NIH |
2010 |
06-25-2010 |
$ 356,675 |
| 066469933 |
5R01HL068630-07 |
MECHANISMS LINKING DEPRESSION TO CARDIOVASCULAR RISK |
NIH |
2010 |
07-29-2010 |
$ 763,719 |
| 066469933 |
5R01HL082609-06 |
THE IMMUNE RESPONSE TO FACTOR VIII |
NIH |
2010 |
08-02-2010 |
$ 483,647 |
| 066469933 |
5R01HL083271-02 |
FUNCTIONAL COUPLING BETWEEN ITO AND ICA IN CARDIOMYOCYTES |
NIH |
2010 |
07-16-2010 |
$ 387,500 |
| 066469933 |
5R01HL092120-02 |
NOXR1, A REGULATOR OF NOX4-DEPENDENT CYTOSKELETAL REMODELING IN VASCULAR CELLS |
NIH |
2010 |
07-27-2010 |
$ 482,087 |
| 066469933 |
5R01HL096924-02 |
POLARITY OF REDOX CONTROL AND RISK OF INJURY IN THE ALVEOLAR EPITHELIUM |
NIH |
2010 |
07-19-2010 |
$ 407,782 |
| 066469933 |
5R01MH082813-02 |
MODELING OFFICER-LEVEL EFFECTS OF CRISIS INTERVENTION TEAM (CIT) TRAINING |
NIH |
2010 |
08-27-2010 |
$ 168,197 |
| 066469933 |
5R01MH089606-02 |
EPIGENETIC MARKS AS PERIPHERAL BIOMARKERS OF AUTISM |
NIH |
2010 |
08-19-2010 |
$ 949,623 |
| 066469933 |
5R03CA136059-02 |
DIETARY INORGANIC PHOSPHATE AS A TARGET FOR NUTRITIONAL INTERVENTION IN CANCER |
NIH |
2010 |
06-30-2010 |
$ 77,500 |
| 066469933 |
5R03HD058777-02 |
IMPACT OF VIDEO VIEWING ON INFANT LEARNING: USING BABY SIGNS AS AN EXPERIMENTAL A |
NIH |
2010 |
07-16-2010 |
$ 77,500 |
| 066469933 |
5R03HD059993-02 |
GENERAL MAGNITUDE REPRESENTATION IN INFANCY: TESTING THE ASSOCIATIONS AMONG SPACE |
NIH |
2010 |
09-01-2010 |
$ 77,381 |
| 066469933 |
5R03HL097012-02 |
VITAMIN D STATUS IN PULMONARY FIBROSIS |
NIH |
2010 |
04-15-2010 |
$ 22,650 |
| 066469933 |
5R03NS066378-02 |
PATIENTS' EXPERIENCES OF EMERGENCY RESEARCH (PEER)- VIEWS OF PATIENTS INCLUDED IN |
NIH |
2010 |
06-29-2010 |
$ 90,283 |
| 066469933 |
5R21AG032104-02 |
MAGNETIC RESONANCE SPECTROSCOPY BASED METABOLOMICS FOR ALZHEIMER'S DISEASE |
NIH |
2010 |
05-03-2010 |
$ 157,831 |
| 066469933 |
5R21AI083554-02 |
THE ROLE OF JAM-A IN REGULATING INTESTINAL ANTIGEN PRESENTING CELL FUNCTION AND I |
NIH |
2010 |
08-11-2010 |
$ 232,500 |
| 066469933 |
5R21DA027080-02 |
IDENTIFICATION OF LOCALIZED MIRNAS FOR NEURONAL DEVELOPMENT AND PLASTICITY |
NIH |
2010 |
05-17-2010 |
$ 193,750 |
| 066469933 |
5R21MH083138-02 |
SCHIZOPHRENIA BIOMARKERS DISCERNED BY CELLULAR NETWORKS IN DIGEORGE SYNDROME |
NIH |
2010 |
04-15-2010 |
$ 193,750 |
| 066469933 |
5R21MH085210-02 |
DEVELOPMENT OF A NOVEL NF-KB ANTAGONIST TO BLOCK CYTOKINE-INDUCED BEHAVIORAL CHAN |
NIH |
2010 |
07-16-2010 |
$ 204,902 |
| 066469933 |
5R21NR011204-02 |
IMPROVING SELF MANAGEMENT AND OUTCOMES IN HEART FAILURE PATIENTS WITH DIABETES |
NIH |
2010 |
07-26-2010 |
$ 232,500 |
| 066469933 |
5R21NS066155-02 |
TOWARDS THE DEVELOPMENT OF A NOVEL TREATMENT FOR EPILEPSY |
NIH |
2010 |
07-22-2010 |
$ 193,750 |
| 066469933 |
5R21RR025822-02 |
ANALYSIS OF UBIQUITINATED PROTEOME |
NIH |
2010 |
09-14-2010 |
$ 67,279 |
| 066469933 |
5R34MH086331-02 |
ADAPTATION OF COUPLES VOLUNTARY COUNSELING AND TESTING (CVCT) FOR US MSM |
NIH |
2010 |
07-28-2010 |
$ 348,851 |
| 066469933 |
5RC1DK086939-02 |
KIDNEY INJURY AND DYSFUNCTION SUPPORT (KIDS) |
NIH |
2010 |
07-25-2010 |
$ 500,000 |
| 066469933 |
5RC1ES018299-02 |
VALIDATION & PILOT TESTING OF METHODS FOR ASSESSING INFANTS' DIETARY PESTICIDE EX |
NIH |
2010 |
07-28-2010 |
$ 238,013 |
| 066469933 |
5RC1GM090950-02 |
CHARACTERIZATION OF THE TRANSCRIPTOME IN AN EMERGING MODEL FOR SOCIAL BEHAVIOR |
NIH |
2010 |
08-27-2010 |
$ 426,250 |
| 066469933 |
5RC1GM091388-02 |
NUCLEAR ORGANIZATION IN STEM AND DIFFERENTIATED CELLS |
NIH |
2010 |
09-13-2010 |
$ 387,500 |
| 066469933 |
5RC1HL100915-02 |
ECONOMIC CONSEQUENCES OF ADVANCED TESTING FOR SUBCLINICAL CARDIOVASCULAR DISEASE |
NIH |
2010 |
08-08-2010 |
$ 497,966 |
| 066469933 |
5RC1HL100951-02 |
HYBRID REVASCULARIZATION VS PERCUTANEOUS CORONARY INTERVENTION: A PLANNING GRANT |
NIH |
2010 |
09-03-2010 |
$ 500,000 |
| 066469933 |
5RC1MD004370-02 |
IMPROVING RACIAL/ETHNIC MINORITY PARTICIPATION IN ONLINE HIV PREVENTION RESEARCH |
NIH |
2010 |
08-17-2010 |
$ 499,456 |
| 066469933 |
5RC1MD004563-02 |
PREVENTING DEPRESSION IN PEOPLE WITH EPILEPSY: AN EXTENSION OF PROJECT UPLIFT |
NIH |
2010 |
07-01-2010 |
$ 475,237 |
| 066469933 |
5RC1MH088467-02 |
PREFRONTAL CORTEX BDNF AND AMYGDALA-DEPENDENT EMOTIONAL LEARNINGCHALLENGE AREA: |
NIH |
2010 |
08-05-2010 |
$ 387,835 |
| 066469933 |
5RC1MH088609-02 |
EPIGENETIC BIOMARKERS OF EARLY PSYCHOTROPIC MEDICATION EXPOSURE |
NIH |
2010 |
08-20-2010 |
$ 488,329 |
| 066469933 |
5RC1MH088985-02 |
SAFETY SIGNAL LEARNING IN RHESUS MONKEYS FOLLOWING EARLY LIFE STRESSCHALLENGE AR |
NIH |
2010 |
07-30-2010 |
$ 404,105 |
| 066469933 |
5RC1NS069234-02 |
NEW FRONTIERS IN OPMD: STEM CELL THEORY OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY |
NIH |
2010 |
08-30-2010 |
$ 500,000 |
| 066469933 |
5RC1NS069541-02 |
COMPREHENSIVE MUTATION DETECTION FOR NEUROMUSCULAR DISORDERS: BRINGING NEW TECHNO |
NIH |
2010 |
08-18-2010 |
$ 500,000 |
| 066469933 |
5RC2CA148265-02 |
NANOTECHNOLOGY FOR MULTIPLEXED AND INTRAOPERATIVE CANCER DETECTION |
NIH |
2010 |
08-25-2010 |
$ 1,017,561 |
| 066469933 |
5RC2CA149086-02 |
PD-1 BLOCKADE COMBINED WITH VACCINATION AS A THERAPY FOR SIV/AIDS |
NIH |
2010 |
07-28-2010 |
$ 499,206 |
| 066469933 |
5RC2HD064525-02 |
CNV ATLAS OF HUMAN DEVELOPMENT |
NIH |
2010 |
08-31-2010 |
$ 1,696,461 |
| 066469933 |
5RC2HG005542-02 |
DYNAMICALLY SCALABLE ACCESSIBLE ANALYSIS FOR NEXT GENERATION SEQUENCE DATA |
NIH |
2010 |
08-27-2010 |
$ 734,945 |
| 066469933 |
5RC2HL101515-02 |
PHASE II STUDY: MOBILIZATION OF PROGENITOR CELLS IN PERIPHERAL ARTERIAL DISEASE |
NIH |
2010 |
08-23-2010 |
$ 1,193,039 |
| 066469933 |
7R21NS059649-03 |
DOPAMINERGIC MODULATION OF COGNITIVE ASPECTS OF SKILL ACQUISITION IN PD |
NIH |
2011 |
04-12-2011 |
$ 187,500 |
| 066469933 |
7RC1DK086577-03 |
GENOME-WIDE ANALYSIS OF RXR-ALPHA BINDING IN MOUSE LIVER CHROMATIN WITH CHIP-SEQ |
NIH |
2012 |
11-25-2011 |
$ 240,590 |
| 066469933 |
7RC1HL100245-03 |
GENETICS OF HYPERTENSION RISK FACTORS AND SEQUELA IN AFRICAN AMERICANS |
NIH |
2012 |
04-24-2012 |
$ 292,030 |
| 066469933 |
7RC1MH088676-03 |
PERFORMANCE INDICES OF SOCIAL DISABILITY IN TODDLERS WITH AUTISM |
NIH |
2012 |
02-14-2012 |
$ 309,227 |
| 066469933 |
A0AHP16404 |
ARRA - PUBLIC HEALTH TRAINEESHIP PROGRAM |
HRSA |
2009 |
09-03-2009 |
$ 70,201 |
| 066469933 |
D5FHP20667 |
ARRA - TRAINING IN PRIMARY CARE MEDICINE AND DENTISTRY: RESIDENCY TRAINING IN PRIMARY CARE |
HRSA |
2010 |
09-03-2010 |
$ 1,322,626 |
| 066469933 |
D5HHP18958 |
ARRA - PREVENTIVE MEDICINE RESIDENCY PROGRAM |
HRSA |
2010 |
07-02-2010 |
$ 668,768 |
| 066469933 |
R21AI079714-3-002 |
FUNCTIONAL CHARACTERIZATION OF THE HEPATITIS C VIRUS E1-E2 GLYCOPROTEINS |
NIH |
2010 |
09-21-2010 |
$ 155,532 |
To continue, click on the Award Title in the list above to obtain detailed data about a specific Award.
The Award Detail screen should display with the data for that award that is available for reporting to FederalReporting.gov.